Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 183

Lycia Pharmaceuticals rakes in $70m

Eli Lilly and Alexandria Real Estate Equities are among the investors in a round that took the protein drug developer’s total funding to over $150m.

Sep 13, 2021

Corporates swoop in for Skydweller’s $40m series A

Palantir and Leonardo have helped solar-powered aircraft technology developer Skydweller fill out its oversubscribed series A funding round.

Sep 13, 2021

Analysis: PayPal pays $2.7bn to Paidy

PayPal is to purchase its portfolio company Paidy, a consumer finance service provider. Paidy is part of the wider payment tech space, which has seen an increasing number of exits since last year.

Sep 13, 2021

Daily Deal Round Up: September 10, 2021

Myeg returned for augmented reality technology developer HiScene's $41.6m series C-plus round while celiac disease drug developer Calypso Biotech hiked a corporate-backed round to over $33m.

Sep 10, 2021

Daily deal net: September 10, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sep 10, 2021

Penn produces iEcure with $50m

Based on technology at University of Pennsylvania, iEcure has launched to commercialise gene therapies initially for liver disorders and an option to license more assets.

Sep 10, 2021

Varo Bank cashes in with $510m round

The Progressive-backed neobank has secured the fresh funding at a reported $2.5bn valuation, seven months after it closed a $63m round.

Sep 10, 2021

Allianz waves AV8 Ventures to $180m fund

Allianz has recommitted to the venture capital firm having funded its $170m debut vehicle two years ago.

Sep 10, 2021

Packable goes for $1.55bn reverse merger

Reckitt Benckiser, Emerson Group, McKesson and Sealed Air are set to score exits from the e-commerce services provider.

Sep 10, 2021

Mammoth Biosciences raises $195m across two rounds

Disease diagnostics technology developer Mammoth Biosciences is valued at over $1bn following funding rounds backed by investors including Amazon.

Sep 10, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here